A Study to Evaluate Rozanolixizumab to Treat Patients with Generalized Myasthenia Gravis
Rochester, MN
The purpose of this study is to assess the safety, tolerability, and effectiveness of additional 6-week treatment cycles with Rozanolixizumab in study participants with generalized myasthenia gravis.